Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$504,588
+$260,598 QoQ
Shares Held
62,995
+107.3% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 209 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. SPRY ranks #184 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in SPRY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $504,588 62,995
2026-03-31 $243,990 30,385
2025-12-31 $865,081 74,256
2025-09-30 $742,110 73,842
2025-06-30 $1,066,299 61,106
2025-03-31 $750,358 59,647
2024-12-31 $439,944 41,701
2024-09-30 $410,929 28,340
2024-06-30 $134,083 15,756
2024-03-31 $87,769 8,588
2023-12-31 $41,089 7,498
2023-09-30 $22,438 5,936
2023-06-30 $63,717 9,510
2023-03-31 $1,588 244
2022-12-31 $2,013 236
2022-09-30 $802 152
2022-06-30 $627 148
2022-03-31 $14,716 4,193
2021-12-31 $56,821 8,532
2021-09-30 $168,770 16,911
2021-06-30 $18,162 588
2021-03-31 $191,186 4,382